Immunomodulatory properties of umbilical cord mesenchymal stromal cells in immune disorders: immunoregulatory functions, therapeutic progress, and engineering strategies for enhanced efficacy
Chenglian Xie, Yongliang Lu, Jie Ma, Manjun Deng, Chuanchuan Liu · 2026
Read Immunomodulatory properties of umbilical cord mesenchymal stromal cells in immune disorders: immunoregulatory functions, therapeutic progress, and engineering strategies for enhanced efficacy by Chenglian Xie, Yongliang Lu, Jie Ma, Manjun Deng, Chuanchuan Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13620463.txt.
Description
Chenglian Xie and co-authors published a review in 2026 on umbilical cord stem cells as immune-calming therapy. Standard immune-suppressing drugs carry heavy side effects and fade over time. Cord-derived stromal cells instead rebalance many immune cell types and release calming signals. The review gathers animal and patient evidence across graft-versus-host disease, lupus, bowel inflammation, and arthritis.
Results so far look promising, yet the path to clinics is clogged. Cells vary batch to batch, preparation lacks shared standards, homing to target tissues is weak, and long-term safety data are thin. The authors map two upgrade routes: smarter culture tricks like low-oxygen priming, and genetic engineering. They aim for stable, scalable cell products.
Catalog record
| CREATOR | Chenglian Xie, Yongliang Lu, Jie Ma, Manjun Deng, Chuanchuan Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 89 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |